RA Kahn MD, DM Moskowitz MD, LH Hollier MD, M
Marin MD
Departments of Anesthesiology and Surgery
The Mount Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029
The correct citation of this article for reference is:
Kahn RA, Moskowitz DM, Hollier LH, Marin M:
The Safety Of High Dose Adenosine For Induction Of Temporary Asystole For Stent-Graft Deployment During Endovascular Abdominal Aortic Aneurysm Repair. The Internet Journal of Anesthesiology 1999; Vol3N3: http://www.ispub.com/journals/IJA/Vol3N3/adenosine.htm; Published July 1, 1999; Last Updated July 1, 1999.Quick
Links
Introduction
Methods
Conclusions
Results
References
Introduction (Back to Quick Links)
Endovascular stent-graft placement has recently become an alternative to conventional surgical treatment of abdominal aortic aneurysms (AAA).
Figure 1: Endovascular Aortic Repair
Table 1: Advantages of endovascular aortic repair
Advantages |
|
Figure 2: Mount Sinai Endovascular Graft

Figure 3: Mount Sinai Endovascular Graft

One technique used for the deployment of the endovascular aortic device employs large balloon angioplasty catheters to expand and secure the proximal stent portion of the endovascular graft to the underlying vessel wall. (Figure 4) These balloons have a large cross sectional area, predisposing them to distal aortic migration as a result of the forward aortic blood flow. This device malposition may result in either occlusion of major arterial branches or incomplete aneurysm exclusion. Many techniques have been advocated to prevent this distal migration. (Table 3) One of these techniques is the administration of high dose adenosine, which results in temporary high degree AV block (2). In this report, we present our experience with the use of high dose adenosine for induction of temporary asystole during endovascular aortic repair (EAR) in 100 patients.
Figure 4: Deployment of the endovascular aortic device

Table 2: Pharmacology of Adenosine
| Adenosine Pharmacology |
|
Table 3: Options
for Prevention of Stent-Graft Migration During Deployment
| Options for Prevention of Stent-Graft Migration During Deployment |
Endovascular repair of AAA were carried out in accordance with investigator sponsored Investigational Device Evaluation protocol from the United States Food Federal Drug Administration, and approval of the Institutional Review Board.
Table 4: Anesthetic Preparation
| Methods Anesthetic Preparation |
|
Table 5: Induction of Asystole
| Methods Induction of Asystole |
|
The records of 100 patients undergoing EAR were reviewed. The dose
range of adenosine administered was 12-90 mg with a median value of 24 mg. Two patients
had transient episodes of myocardial ischemia (diagnosed by ST segment depression), which
resolved within 30 seconds after return of the patients baseline rhythm. Two
patients developed atrial fibrillation after adenosine administration, which responded to
synchronized direct current cardioversion, and one patient developed a transient bundle
branch block, which did not adversely effect hemodynamics. Four patients required
temporary activation of their indwelling temporary transvenous pacemakers for prolonged
bradycardia or AV block after adenosine. No patients developed bronchospasm, required
treatment for worsening obstructive pulmonary disease, or received inotropic support that
was not required prior to adenosine administration.
Table 6: Results of the Study
| Study Results |
|
Conclusions (Back to Quick Links)
EAR is a viable alternative to conventional open surgical aortic
reconstruction. The perioperative use of high dose adenosine to ensure precise stent-graft
placement appears to be a safe method of inducing temporary asystole during endovascular
aortic repair in this high risk surgical population.
Table 7: Conclusions of the Study
| Study Conclusions |
|
References (Back to Quick Links)
© Internet Scientific Publications, L.L.C., 1996 to 1999.
First Published: October 1996
The Internet Journal of Anesthesiology
The Internet Journal of Emergency and
Intensive Care Medicine